Metabolic Syndrome Observation on a Regional Basis (ORSA Umbria)

AstraZeneca

Status: Completed

Conditions: Metabolic Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT00933010

NIS-CIT-DUM-2008/1

Details and patient eligibility

About

The aim of the study is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Enrollment: 1,600 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient aged between 18 and 75 years
• Signed Informed consent
• Laboratory analysis (lipidic profile and glycemia) performed in the last year

Exclusion criteria

• Pregnancy or breast feeding
• Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs
• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study